AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2013
Apr 18, 2013
32870_dirs_2013-04-18_3ef7b682-1856-46db-ad22-ee94d1e2a738.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2013-03-14
Reporting Person: El-Hibri Fuad (Director, Chairman, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-03-14 | Common Stock | F | 3659 | $14.46 | Disposed | 1857532 | Direct |
Footnotes
F1: This amendment on Form 4/A is being filed to correct the date of the transaction to March 14, 2013. Except as described in footnote 2, there are no other changes from the information originally reported on the Form 4 as originally filed on March 18, 2013.
F2: This amendment on Form 4/A is being filed to correct an overstatement of 635 shares in the amount of securities disposed of by the reporting person and to correct the resulting amount of securities beneficially owned by the reporting person following such disposition. Except as described in footnote 1, there are no other changes from the information originally reported on the Form 4 as originally filed on March 18, 2013.
F3: Mr. El-Hibri's direct holdings include restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.